Oxidative stress is one of the 'most important factors' that causes aging — here's what you can do to reduce it
Oxidative stress is one of the primary drivers of aging, but your diet can play a role in tamping it down — or accelerating it.
Experts have long linked our diets — particularly those high in fat or carbohydrates — to increased inflammation and oxidative stress. Oxidative stress is an imbalance between free radicals (the bad guys) and antioxidants (the good guys) in the body. It plays a role in several chronic and degenerative conditions, including cancer, cardiovascular disease, rheumatoid arthritis, in addition to neurological and respiratory diseases.
While oxidative stress is a natural process that occurs in all living organisms, we can take steps to reduce its impact and, in turn, lessen the hallmarks of aging.
This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Contact a qualified medical professional before engaging in any physical activity, or making any changes to your diet, medication or lifestyle.
The North American lifestyle, in general, "is not very healthy and is harmful," Dr. Cory S. Goldberg, a plastic and craniofacial surgeon and former Division Head of Plastic Surgery at Trillium Health Partners, told Yahoo Canada. "We can definitely live better and longer with some basic principles and implementations."
Oxidative stress ages you "in an absolute way," he said. "It is probably one of the most important factors that cause aging."
Anything that raises the number of free radicals in your body, triggering an imbalance, can cause oxidative stress. Pollution, stress, smoking, sun exposure and excessive alcohol consumption all cause oxidative stress, but it's also heavily influenced by diet.
"The food we eat is probably the biggest and most important contributing factor to having bad health and bad skin," Goldberg, who is certified in functional medicine, said.
"There is a direct relation between your gut bacteria and your skin, and also between your gut bacteria and your brain and your psychological health and emotional well-being," he said. "In fact, a majority, about 90 per cent of your serotonin, is produced in your intestines, not in your brain."
Imagine your body is like a power plant or production facility. The power plant produces energy, proteins and the things that make you function. It also creates waste as a byproduct of those processes, Goldberg explains. "Your body is constantly mopping up [that waste]."
However, "it takes energy to do that, and if it doesn't get fully mopped up, it harms you quite a lot."
Your diet, especially eating foods that are high in antioxidants — berries, kale, pecans, beans and dark chocolate, for example — is crucial because it helps you manage this oxidative stress.
"There is no one diet that fits everybody. There's no gospel on diet," Goldberg said. "Principles are usually the best things to follow, and ultimately, what each individual needs differs and what one would need over their lifetime changes."
A good place to start is by eliminating or reducing your consumption of ultra-processed foods.
Public health experts have long warned about the dangers of ultra-processed foods — manufactured foods that have been highly processed and often contain additives — and a 2025 study confirmed the association between their consumption and all-cause mortality.
The research, which involved more than 240,000 people, found that "every bite" of ultra-processed food can increase your risk of early death.
Goldberg said that if someone were to drastically reduce their intake of ultra-processed foods, say from 60 per cent of their caloric intake to 10 per cent of their caloric intake, it would make a "huge difference" in the amount of inflammation in the body.
Reducing your consumption of ultra-processed foods would not only decrease the risk of premature death and certain diseases, said Goldberg, but it would also make a significant difference in skin health and the hallmarks of premature aging.
"What manifests on the skin is more than just the soft descriptor of 'looks flat' or 'doesn't have a glow,'" Goldberg said. "What's actually manifesting is inflammation. Your skin is responding to the toxins that are being released by the bacteria in your intestine if they are unhealthy bacteria."
If you're eating foods that "tend to propagate the unhealthy bacteria," it can cause inflammation and skin disorders. Eczema, skin irritations and inflammation are "absolutely worsened by imbalances of gut bacteria."
One of the easiest ways to improve the gut microbiome is by eating more fruits and vegetables and incorporating colour into your diet. Eating the rainbow, Goldberg advised, is a great way to integrate more and varied nutrients into your daily life.
Additionally, the plastic surgeon recommended a supplement called GliSODin, which he referred to as "the thing" for managing oxidative stress.
GliSODin, an antioxidant enzyme, contains superoxide dismutase [SOD], which in biochemistry, people call the "king of enzymes," Goldberg explained.
"It is, quite possibly, one of the, if not the most important, enzymes our body produces because it is the thing that allows us to manage this oxidative stress."
"There's not a lot of ways to up your SOD," but GliSODin is one of them.
"I have all my surgical patients take it," he said. "I did a study on this stuff 10 years ago, measuring skin inflammation with images [...] and after just three months of taking it, there was a statistically significant reduction in skin inflammation."
Goldberg, who is a voluntary scientific advisor for the company, said taking the enzyme was a "no-brainer."
"It has been shown to have benefits in every organ system," he said. "I think that it should be put in the water."
While studies agree there are "therapeutic potentials of superoxide dismutase," other experts warn the enzyme is not easily absorbed into the bloodstream when taken orally and question the benefits of oral supplements.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Associated Press
40 minutes ago
- Associated Press
PathAI Receives FDA Clearance for AISight® Dx Platform for Primary Diagnosis
BOSTON, June 30, 2025 (GLOBE NEWSWIRE) -- PathAI, a global leader in artificial intelligence (AI) and digital pathology solutions, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for AISight® Dx *—its digital pathology image management system—for use in primary diagnosis in clinical settings. Building on the initial 510(k) clearance for AISight Dx(Novo) in 2022, this latest milestone underscores the platform's continuous innovation and PathAI's commitment to delivering enhanced capabilities as the product evolves. The FDA decision also included a Predetermined Change Control Plan (PCCP), enabling PathAI to validate and implement specified major changes such as additional displays, scanners, file formats and browsers into AISight Dx without requiring additional 510(k) submissions. This proactive regulatory alignment accelerates future software updates and hardware integrations, allowing faster innovation while ensuring continued FDA compliance. AISight Dx is a cloud-native digital pathology platform designed to maximize efficiency in anatomic pathology workflows. From intelligent case management to high-performance slide review and seamless live collaboration, AISight Dx helps labs accelerate turnaround times and optimize pathologist productivity. With integrated image management, synchronized multi-slide navigation, and robust annotation tools, the platform eliminates manual bottlenecks and supports faster, more consistent diagnoses. Designed for interoperability, compliance, and scale, AISight Dx empowers anatomic pathology labs, hospital systems, and academic medical centers to modernize operations and deliver high-quality patient care with confidence. 'Digital pathology is the future of diagnostic medicine, empowering pathologists to work more efficiently and collaborate quickly without being limited to physical specimen review,' said Andy Beck, M.D., Ph.D., CEO of PathAI. 'This 510(k) clearance showcases our commitment to quality and scientific rigor at PathAI and provides us a way forward to continually enhance our AISight Dx IMS.' Learn more about AISight Dx here. * AISight® Dx is FDA-cleared (K243391) for primary diagnosis in the US with the Hamamatsu NanoZoomer® S360MD and Leica Aperio® GT 450 DX slide scanners, and is CE‑IVD–marked for primary diagnosis in the EEA, UK, and Switzerland. About PathAI PathAI is a leading provider of AI-powered pathology solutions that aim to improve the accuracy of histology assessment and accelerate drug development. PathAI's platform leverages advanced artificial intelligence to analyze and interpret pathology images, providing valuable insights to pathologists, researchers, and pharmaceutical companies. PathAI is headquartered in Boston, MA. For more information, please visit and follow us on LinkedIn. Company Contact Liz Storti Chief People Officer [email protected] Media Contact Owen Blaschak LifeSci Communications [email protected]
Yahoo
an hour ago
- Yahoo
Telemedicine Demand Boosts Growth, North America and Europe Lead System Utilization
The Global Portable Patient Monitoring System Market is estimated to grow from USD 11.83 Billion in 2025 to USD 20.65 Billion by 2034, at a CAGR of 8.3%. Key trends include enhanced sensor technology, wireless connectivity, and real-time data solutions. North America leads in adoption, while Asia-Pacific shows high growth rates. Portable Patient Monitoring System Market Dublin, June 26, 2025 (GLOBE NEWSWIRE) -- The "Portable Patient Monitoring System Market Size, Share, Trends, Analysis, and Forecast 2025-2034 | Global Industry Growth, Competitive Landscape, Opportunities, and Challenges" report has been added to Global Portable Patient Monitoring System Market Size is valued at USD 11.83 Billion in 2025. Worldwide sales of Portable Patient Monitoring System Market are expected to grow at a significant CAGR of 8.3%, reaching USD 20.65 Billion by the end of the forecast period in 2034. The Portable Patient Monitoring System Market is a rapidly growing sector within healthcare technology, providing mobile solutions that enable continuous tracking of vital patient parameters. These systems, often designed as lightweight, compact devices or wearable units, monitor key health indicators such as heart rate, blood pressure, oxygen saturation, respiratory rate, and allowing patients to remain mobile or receive care outside traditional clinical settings, portable patient monitoring systems enhance patient comfort and convenience while ensuring timely data for healthcare providers. They are used in a wide range of applications, from remote patient management and home care to ambulatory care settings and post-surgery recovery, offering healthcare professionals the ability to identify potential complications early and adjust treatment plans as 2024, the market continues to expand due to advancements in sensor technology, wireless connectivity, and data analytics. North America and Europe lead adoption, driven by established healthcare infrastructures, supportive reimbursement frameworks, and a growing focus on preventative care. Asia-Pacific is emerging as a high-growth region, fueled by rising chronic disease prevalence, expanding healthcare access, and increased investment in telehealth innovations, including Bluetooth-enabled devices, mobile app integration, and cloud-based data storage, are driving demand by improving user experience and making real-time data sharing more efficient. As healthcare systems worldwide shift toward more patient-centric models and telemedicine becomes more prevalent, portable patient monitoring systems are poised to remain integral to modern healthcare Takeaways Portable patient monitoring systems provide real-time tracking of vital health metrics in non-clinical environments. These devices are lightweight, compact, and increasingly integrated with mobile applications and cloud platforms. North America and Europe lead in adoption due to advanced healthcare systems, reimbursement support, and emphasis on preventative care. Asia-Pacific is a rapidly growing market, driven by rising chronic diseases, expanding healthcare access, and growing telehealth initiatives. Improved sensor technology and wireless connectivity are enabling more accurate and reliable portable monitoring solutions. Consumer-friendly interfaces and user-friendly designs enhance patient adherence and satisfaction. Technological advancements include longer battery life, reduced device size, and improved data visualization through apps. Data integration with electronic health records (EHR) streamlines care coordination and enables timely interventions. Telehealth adoption is expanding the use of portable monitors for remote consultations and chronic condition management. Reimbursement policies for remote monitoring and home-based care support wider adoption of these devices. Safety and regulatory compliance, including HIPAA and GDPR, remain critical for data security and patient trust. Portable patient monitors are increasingly used in post-surgical care and chronic disease management, improving outcomes and reducing hospital readmissions. Innovative partnerships between technology providers and healthcare organizations are driving product enhancements and market growth. Challenges include high device costs, data interoperability issues, and regulatory complexities in emerging markets. Future growth is likely to come from expanding telemedicine services, continued technological advancements, and growing healthcare consumerization trends. Key Attributes: Report Attribute Details No. of Pages 150 Forecast Period 2025 - 2034 Estimated Market Value (USD) in 2025 $11.83 Billion Forecasted Market Value (USD) by 2034 $24.25 Billion Compound Annual Growth Rate 8.3% Regions Covered Global Companies Featured Philips Healthcare GE Healthcare Medtronic plc Masimo Corporation Abbott Laboratories Fresenius Kabi Omron Healthcare, Inc. Honeywell Life Sciences BioTelemetry, Inc. (a Philips company) iHealth Labs Withings Boston Scientific Corporation ResMed Inc. Cardiac Science Corporation Hill-Rom Holdings, Inc. (now part of Baxter International) Market Scope Base Year: 2024 Estimated Year: 2025 Forecast Period: 2026-2032 Portable Patient Monitoring System Market Segmentation By Type Wearable Monitors Handheld Monitors Stationary Monitors By Application Chronic Disease Management Home Healthcare Wellness Monitoring By End User Hospitals Homecare Settings Ambulatory Surgical Centers By Technology Bluetooth Wi-Fi Cellular By Distribution Channel Online Offline By Geography North America (USA, Canada, Mexico) Europe (Germany, UK, France, Spain, Italy, Rest of Europe) Asia-Pacific (China, India, Japan, Australia, Vietnam, Rest of APAC) The Middle East and Africa (Middle East, Africa) South and Central America (Brazil, Argentina, Rest of SCA) For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Portable Patient Monitoring System Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data


Washington Post
an hour ago
- Washington Post
Did genes or ancestry make the Manning brothers? Why not both?
The field of sports genomics is rife with argument, starting with the simple question of what athleticism even is. For every study that shows a relationship between ribonucleic acids and raising trophies, another contradicts it. The interplay of slow- and fast-twitch fibers that makes balance, concentration, spatial awareness, these are not traits like hair color. Maybe someday genomics will be a useful predictor of whether you're growing a Hall of Famer at your kitchen table, but for the moment, it's overneat to the point of uselessness. If you're going down the rabbit hole of athleticism, at least go down a more intriguing path that embraces the messiness and mystery: genealogy.